147 related articles for article (PubMed ID: 24103199)
1. Asparagus racemosus ameliorates cisplatin induced toxicities and augments its antileishmanial activity by immunomodulation in vivo.
Sachdeva H; Sehgal R; Kaur S
Parasitol Int; 2014 Feb; 63(1):21-30. PubMed ID: 24103199
[TBL] [Abstract][Full Text] [Related]
2. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
Sachdeva H; Sehgal R; Kaur S
Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
[TBL] [Abstract][Full Text] [Related]
3. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.
Sachdeva H; Sehgal R; Kaur S
Parasitol Res; 2013 Jun; 112(6):2269-80. PubMed ID: 23519426
[TBL] [Abstract][Full Text] [Related]
4. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
Joshi J; Kaur S
Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial effect of cisplatin against murine visceral leishmaniasis.
Kaur S; Sachdeva H; Dhuria S; Sharma M; Kaur T
Parasitol Int; 2010 Mar; 59(1):62-9. PubMed ID: 19853668
[TBL] [Abstract][Full Text] [Related]
6. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.
Joshi J; Malla N; Kaur S
Parasitol Int; 2014 Aug; 63(4):612-20. PubMed ID: 24747611
[TBL] [Abstract][Full Text] [Related]
7. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.
Islamuddin M; Chouhan G; Farooque A; Dwarakanath BS; Sahal D; Afrin F
PLoS Negl Trop Dis; 2015 Jan; 9(1):e3321. PubMed ID: 25568967
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin along with herbal drug treatment reduces the percentage of regulatory T cells and decreased the severity of experimental visceral leishmaniasis.
Sachdeva H; Kaur S
J Microbiol Immunol Infect; 2018 Aug; 51(4):435-445. PubMed ID: 28655574
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
[TBL] [Abstract][Full Text] [Related]
10. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
[TBL] [Abstract][Full Text] [Related]
11. Antileishmanial efficacy of Boerhaavia diffusa L. and Ocimum sanctum L. against experimental visceral leishmaniasis.
Kaur S; Bhardwaj K; Sachdeva H
Indian J Exp Biol; 2015 Aug; 53(8):522-9. PubMed ID: 26349315
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
13. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
14. Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus.
Kaur S; Chauhan K; Sachdeva H
J Med Microbiol; 2014 Oct; 63(Pt 10):1328-1338. PubMed ID: 25082945
[TBL] [Abstract][Full Text] [Related]
15. To investigate the therapeutic potential of immunochemotherapy with cisplatin + 78 kDa + MPL-A against Leishmania donovani in BALB/c mice.
Joshi J; Kaur S
Parasite Immunol; 2014 Jan; 36(1):3-12. PubMed ID: 23964700
[TBL] [Abstract][Full Text] [Related]
16. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
[TBL] [Abstract][Full Text] [Related]
17. Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis.
Shakya N; Sane SA; Vishwakarma P; Gupta S
Exp Parasitol; 2012 Jul; 131(3):377-82. PubMed ID: 22626518
[TBL] [Abstract][Full Text] [Related]
18. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
Asad M; Bhattacharya P; Banerjee A; Ali N
BMC Infect Dis; 2015 Apr; 15():188. PubMed ID: 25884796
[TBL] [Abstract][Full Text] [Related]
20. Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice.
Kaur J; Kaur T; Kaur S
Acta Trop; 2011 Jul; 119(1):50-6. PubMed ID: 21530477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
